Sciencast Management LP purchased a new stake in shares of Colgate-Palmolive (NYSE:CL) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 4,796 shares of the company’s stock, valued at approximately $356,000.
A number of other institutional investors and hedge funds have also recently made changes to their positions in the business. Blue Chip Partners Inc. boosted its position in Colgate-Palmolive by 0.4% during the 2nd quarter. Blue Chip Partners Inc. now owns 1,813 shares of the company’s stock valued at $134,000 after buying an additional 8 shares during the period. Cue Financial Group Inc. lifted its position in shares of Colgate-Palmolive by 0.3% in the 2nd quarter. Cue Financial Group Inc. now owns 4,854 shares of the company’s stock worth $360,000 after purchasing an additional 14 shares during the period. Cornerstone Financial Partners LLC lifted its position in shares of Colgate-Palmolive by 0.5% in the 2nd quarter. Cornerstone Financial Partners LLC now owns 3,813 shares of the company’s stock worth $282,000 after purchasing an additional 19 shares during the period. M Holdings Securities Inc. lifted its position in shares of Colgate-Palmolive by 0.4% in the 1st quarter. M Holdings Securities Inc. now owns 5,366 shares of the company’s stock worth $393,000 after purchasing an additional 21 shares during the period. Finally, AlphaMark Advisors LLC lifted its position in shares of Colgate-Palmolive by 1.5% in the 2nd quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock worth $126,000 after purchasing an additional 25 shares during the period. 72.96% of the stock is owned by institutional investors and hedge funds.
Several research firms have recently commented on CL. Zacks Investment Research raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $80.00 target price for the company in a research report on Monday, September 25th. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $74.00 target price on shares of Colgate-Palmolive in a research report on Sunday, October 8th. Macquarie began coverage on shares of Colgate-Palmolive in a research report on Thursday, September 14th. They issued a “neutral” rating and a $76.00 target price for the company. Morgan Stanley raised shares of Colgate-Palmolive from an “equal weight” rating to an “overweight” rating and raised their target price for the stock from $75.00 to $84.00 in a research report on Monday, September 25th. Finally, Jefferies Group dropped their target price on shares of Colgate-Palmolive from $79.00 to $76.00 and set a “hold” rating for the company in a research report on Monday, October 30th. Two research analysts have rated the stock with a sell rating, fifteen have given a hold rating and four have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus price target of $76.04.
Colgate-Palmolive (CL) opened at $74.52 on Tuesday. Colgate-Palmolive has a 12-month low of $63.43 and a 12-month high of $77.27. The stock has a market cap of $64,136.80, a PE ratio of 25.45, a P/E/G ratio of 3.34 and a beta of 0.81. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.92 and a current ratio of 1.23.
Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, October 27th. The company reported $0.73 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.73. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The company had revenue of $3.97 billion during the quarter, compared to analysts’ expectations of $3.94 billion. During the same period last year, the company posted $0.73 EPS. Colgate-Palmolive’s revenue was up 2.8% on a year-over-year basis. equities analysts anticipate that Colgate-Palmolive will post 2.88 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which was paid on Wednesday, November 15th. Investors of record on Monday, October 23rd were given a dividend of $0.40 per share. The ex-dividend date of this dividend was Friday, October 20th. This represents a $1.60 dividend on an annualized basis and a yield of 2.15%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 61.78%.
In other Colgate-Palmolive news, insider Victoria L. Dolan sold 10,000 shares of the firm’s stock in a transaction dated Thursday, November 9th. The shares were sold at an average price of $73.07, for a total transaction of $730,700.00. Following the completion of the sale, the insider now directly owns 60,528 shares in the company, valued at approximately $4,422,780.96. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, COO Justin Skala sold 126,393 shares of the firm’s stock in a transaction dated Thursday, November 9th. The shares were sold at an average price of $72.97, for a total transaction of $9,222,897.21. Following the sale, the chief operating officer now owns 262,361 shares of the company’s stock, valued at $19,144,482.17. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 173,673 shares of company stock valued at $12,629,293. 1.02% of the stock is owned by company insiders.
COPYRIGHT VIOLATION NOTICE: This news story was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this news story on another domain, it was illegally copied and reposted in violation of US & international trademark and copyright law. The legal version of this news story can be accessed at https://www.dispatchtribunal.com/2017/12/05/4796-shares-in-colgate-palmolive-cl-acquired-by-sciencast-management-lp.html.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.